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Abstract
MicroRNAs (miRNAs) posttranscriptionally regulate targeted messenger RNAs (mRNAs) by inducing cleavage or otherwise
repressing their translation. We address the problem of detecting m/miRNA targeting relationships in homo sapiens from
microarray data by developing statistical models that are motivated by the biological mechanisms used by miRNAs. The
focus of our modeling is the construction, activity, and mediation of RNA-induced silencing complexes (RISCs) competent
for targeted mRNA cleavage. We demonstrate that regression models accommodating RISC abundance and controlling for
other mediating factors fit the expression profiles of known target pairs substantially better than models based on m/
miRNA expressions alone, and lead to verifications of computational target pair predictions that are more sensitive than
those based on marginal expression levels. Because our models are fully independent of exogenous results from sequence-
based computational methods, they are appropriate for use as either a primary or secondary source of information
regarding m/miRNA target pair relationships, especially in conjunction with high-throughput expression studies.
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Introduction
Micro RNAs (miRNAs) are small (20–22 bp) RNAs transcribed
by a wide variety of organisms, from viruses [1], to plants [2,3], to
animals such as C. elegans, Drosophila and humans [4–6]. While
most RNAs function in ribosomes or splicesomes, or are translated
into proteins necessary for cellular function, miRNAs instead serve
as negative regulators of gene expression by preventing the
translation of messenger RNAs (mRNAs). Through their regula-
tory activities, miRNAs have been shown to affect organismal
development, physiological function and stress responses. Abnor-
mal miRNA production has also been associated with the
development of several types of cancer [7–10].
Posttranscriptional gene silencing through miRNA activity occurs
through a multistep process (Figure 1) [11–17] with an overall
structure that has been remarkably conserved across organisms. This
process begins with primary miRNA transcripts (pri-miRNAs) being
either transcribed from ‘‘miRNA genes’’ or spliced from the intronic
regions of mRNAs. In the nucleus, pri-miRNAs fold into hairpin
structures from which trailing 39 and 59 ends are cleaved away by the
RNase Drosha. The resulting precursors to mature miRNAs (pre-
miRNAs) are then exported from the nucleus to the cytoplasm,where
a second RNase enzyme (Dicer) removes the hairpin loop. This
produces a segment of double stranded RNA that is separated into
two single strands by helicase enzymes. After separation, one of the
single stranded RNAs is combined with an Argonaute (Ago) protein
to form an RNA-induced silencing complex (RISC). (Although other
proteins may be incorporated into the structure, an Ago protein and
miRNA compose a minimal functional RISC [18,19].) Once
assembled, RISCs composed of a given miRNA interfere with the
translation of select mRNAs by hybridizing to them at target sites
complementary to the miRNA sequence and either cleaving the
mRNA or blocking its translation while leaving the molecule intact.
Any mRNA translationally regulated by a particular miRNA can be
anticipated to have a limited number of target sites usable by that
miRNA. Each miRNA can target multiple mRNAs, and an mRNA
may contain target sites for multiple miRNAs.
While both mRNA cleavage and blocking ribosomal activity
disrupt translation, the latter does not directly alter mRNA
abundance. Whether a particular RISC cleaves or blocks
translation is determined by both the qualities of the hybridization
and properties of the Ago protein contained in the RISC. The
number and function of distinct Ago proteins shows substantial
variability across organisms. For example, in Arabidopsis there are
10 different variants of Ago and miRNAs preferentially associate
with only one in forming RISCs [20,21], while in humans there
are 4 commonly coexpressed Ago proteins, and miRNAs can be
effectively regarded to have equal propensity to combine with each
[22,23]. The variant of Ago primarily utilized by miRNAs in
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with previous observations that the dominant means of miRNA-
based regulation of mRNA translation is cleavage rather than
translational repression. In humans, only RISCs composed of Ago
2 have been demonstrated to have the ability to cleave and
degrade targeted mRNAs [22,24]. Since miRNAs have equal
propensity to combine with each of these, it is reasonable to
conclude that targeted mRNAs are repressed through a combi-
nation of both cleavage and ribosomal blockage. This is consistent
with results described by Nakamoto et al [25] which demonstrate
simultaneous increases in both target mRNA and polyribosomal
fraction in human miRNA knockdown studies, and recent
experiments reported by Bartel et al [26] that suggest in mice
(which share many of the complexities found in human Ago
properties and RISC formation), most mRNA targets of miRNA-
mediated repression are cleaved.
To determine whether a miRNA targets a particular mRNA,
sequence-based computational target prediction methods may be
used to identify potential miRNA hybridization sites within that
mRNA [27–34]. Algorithms such as miRanda [35] use m/miRNA
alignments and hybridization energies as metrics to score mRNA
subsequences, and report high-scoring subsequences as putative
target sites. More recently proposed methods additionally utilize
evolutionary conservation of a predicted site across multiple
organisms (PicTar [36]), information regarding target site position
and base content (TargetScan [37–39]), or mRNA secondary
structure [40] to improve prediction performance. Although
existing computational target prediction algorithms provide
important information regarding potential m/miRNA target
pairings, they are acknowledged to have issues with specificity
and sensitivity [29,30] as well as inter-algorithm consistency
[30,34]. (These issues are discussed in relation to this study in the
Methods and Discussion sections.) The problem of how to reliably
predict target pair relationships from sequence data alone is
currently unresolved.
Withthelimitationsofpurelysequence-basedmethodsofmiRNA
target prediction, it has been suggested that the statistical analysis of
expression data may play an important role not only in verifying
computationally predicted m/miRNA targeting relationships, but
also for generating de novo target pair predictions [27,29]. Such
analysis would require that both mRNA and miRNA abundance be
measured on the same tissue samples, and naturally would consider
the marginal correlation between a miRNA and its putative target.
Marginal approaches are attractive because they are simple and
they aim to capture the fundamental negative relationship between
miRNAs and their targets. However, determining reliable and
replicable targeting relationships through marginal expression
comparisons either on their own or in combination with
computational prediction has proven to be difficult both previously
[41] and in our own analysis (see following results).
We hypothesize that statistical models guided by knowledge of
the miRNA pathway can be used to reduce error in both
validating and predicting targeting relationships. The premise of
our approach is that although a negative abundance relationship
may exist in an m/miRNA pair, this relationship may only be
detectable within the context of the abundance of other molecules
that participate in mRNA silencing. In a marginal comparison of
m/miRNA expression levels for the purpose of verifying a
predicted targeting relationship, miRNA expressions are com-
Figure 1. miRNA biogenesis and gene silencing. miRNA biogenesis begins with transcription of a pri-miRNA which is processed into a hairpin,
exported from the nucleus, processed into a mature miRNA, and incorporated into a RISC. Minimal functional RISCs consist of an Argonaute protein
and a miRNA. RISCs hybridize to mRNAs at targeting sites complementary with the miRNA, and prevent translation by either cleaving the mRNA or
maintaining its position at the target site and stopping ribosomal activity.
doi:10.1371/journal.pcbi.1000516.g001
Author Summary
MicroRNAs are a family of small RNAs that play important
roles in the development, physiological function and stress
responses of a wide variety of organisms, and if abnormally
expressed are associated with multiple types of cancer in
humans. Rather than being translated into proteins,
members of the family of microRNAs operate by prevent-
ing the translation of messenger RNAs to which they have
some degree of sequence complementarity. Although
sequence-based bioinformatics techniques have yielded
large numbers of predicted messenger- and microRNA
targeting relationships, verifying these as bona fide has
proven practically difficult. We have developed a novel
statistical approach based on the system biology of
microRNAs in humans to detect such targeting relation-
ships using high-throughput RNA expression data. Be-
cause our approach is not based on information from
external target pair predictions, it can play a fully
independent role in verifying such predictions as well as
be used to obtain de novo target pair predictions. Using
two separate data studies, we show that our approach is
capable of both reproducing previously observed target
pairs and verifying putative target pairs predicted from
sequence data, at rates substantially better than marginal
comparisons of messenger- and microRNA expression
levels.
Statistical Use of RISC in miRNA Identification
PLoS Computational Biology | www.ploscompbiol.org 2 September 2009 | Volume 5 | Issue 9 | e1000516pared directly to those of a putatively targeted mRNA. When
expression data from homo sapiens are under study, such a
comparison uses miRNA expressions as a direct substitute for
those of RISC composed of Ago 2 protein and a targeting miRNA.
Additionally, marginal comparisons do not compensate for
indirect effects on mRNA abundance caused by the blocking
RISCs composed of Ago 1, 3 or 4 proteins and the targeting
miRNA. Although ceteris parabis increases of the levels of these
RISCs cannot observably reduce the concentration of the targeted
mRNA, because they utilize the same target sites as RISCs
containing Ago 2 such increases can be anticipated to affect the
ability of Ago 2 RISCs to cleave targeted mRNAs. Finally,
marginal comparisons do not compensate for either the targeting
of the mRNA in a putative target pair by RISCs constructed from
miRNAs other than that under consideration, or targeting of
mRNAs other than the one under analysis by the miRNA.
In this paper, we develop a linear regression model that
accounts for a variety of elements and interactions in the human
miRNA pathway and that compensates for idiosyncratic aspects of
two data collections on which it is applied. Central to this model is
the comparison of the expression levels of a putatively targeted
mRNA to a proxy for RISC expression composed of an
interaction between Ago 2 and a targeting miRNA, rather than
to miRNA expression alone. To demonstrate that our approach
offers superior performance to marginal m/miRNA comparisons,
we compare the two methods on sets of m/miRNA pairs both
previously shown and predicted to have targeting relationships
using expression data from two different studies as well as a
combination of the data. We find that: 1) the system biological
regression approach explains a higher proportion of the observed
variation in known mRNA target levels, even after compensating
for increases in model complexity. 2) The estimated effects of
proxies to targeting Ago 2 RISC expressions on the expressions of
known mRNA targets are more consistently and appropriately
negative than those of marginal miRNA expressions. 3) A larger
number of known m/miRNA target pairs are identified as such
using the regression approach compared to marginal m/miRNA
methods. 4) The system biological regression approach provides
evidence supporting substantially more computationally predicted
m/miRNA pairs as bona fide than do marginal m/miRNA
comparisons. Because we obtain these improvements in perfor-
mance without directly utilizing exogenous information from
sequence-based computational target prediction methods, our
approach provides a basis for statistical methods to putative m/
miRNA target pair analysis that can play useful roles in both
verifying computational target predictions as well as generating de
novo information regarding m/miRNA target relationships.
Methods
Regression modeling
There are two categories of covariates that ought to be
compensated for when comparing the expression levels from a
putative m/miRNA target pair in homo sapiens for the purpose of
inferring a targeting relationship: those corresponding to elements
of the miRNA system biology, and those corresponding to
idiosyncratic data effects (if any). Of these two categories,
covariates related to the miRNA system biology can be further
subdivided into those pertaining to the effect of the particular
miRNA under analysis on the putatively targeted mRNA rather
than that of other miRNAs potentially targeting the mRNA, those
related to observable target cleavage rather than those resulting in
translational repression without cleavage through a maintained
hybridization at a target site, and those related to the affinity of
both the miRNA under analysis as well as other miRNAs to
mRNAs not under direct consideration.
It can be presumed that the covariates in these categories are
related to one another and to target mRNA expression in a
complicated and nonlinear manner, and any statistical or
computational procedure for inferring m/miRNA targeting rela-
tionships ought to have some degree of fidelity to the system biology
represented by the model it is explicitly or implicitly based upon.
However, the fidelity of the model also should be balanced against
the need for a computationally efficient procedure that works well
given the limitations of sample size and the levels of variation in the
system. A well-formulated regression model is computationally
tractable (especially if large numbers of putative m/miRNA pairs
are to be evaluated) and is a standard approach to decomposing
variation in a response. Further, although a linear formulation may
not emerge from first principles, it may capture the dominant
relationships sufficiently well to identify bona fide targeting
relationships. Thus we relate the categories of system biologic
covariates to the expression of a putatively targeted mRNA as in (1):
½message ~½putative cleaving RISC z½putative blocking RISC 
z½non-specific cleaving RISC 
z½non-specific blocking RISC 
z½other targets z½idiosyncratic effects znoise
ð1Þ
where [message] refers to expression of the putative targeted mRNA;
[putative cleaving RISC] represents the effect of RISCs composed of
the putative targeting miRNA and Ago 2 on the targeted mRNA;
[putative blocking RISC] is the effect of RISCs composed of the
putative targeting miRNA and Ago 1, 3 or 4; [non-specific cleaving
RISC] is the effect of RISCs composed of Ago 2 and miRNAs not
underparticularconsideration;[non-specificblockingRISC] isthe effect
of RISC composed of Ago 1, 3 or 4 and the unconsidered miRNAs;
[other targets] refers to the effect that the expression of other mRNAs
have on the putative targeted mRNA, especially through their
affinity for interactions with the putative targeting miRNA;
[idiosyncratic effects] are dataset-specific effects; noise represents natural
variation in [message] as well as that due to systemic effects not
adequately captured in our model.
Although the levels of RISCs of various types used in (1) are
unobserved in RNA microarray expression level measurements,
proxies to them can be obtained using available microarray
expression data by constructing interaction terms from observable
targeting miRNA Ago RNA levels. This preserves a representation
of the relevant miRNA biology leading to target cleavage while
avoiding complications leading to model nonlinearities, such as
seen in equilibrium points of typical chemical kinetics systems. We
note that Ago RNA levels are proxies to (unobserved) protein
levels. As discussed in Protocol S1, the microarray data was
processed to approximate mRNA concentration levels. We assume
that these levels are positively related to protein concentration, and
so the interaction between Ago mRNA and targeting miRNA
levels ought to be positively related to RISC concentration.
Model(2)refinesthesystembiologicalelementsin(1)andprovides
the beginningsof a formal statisticalmodel.Let i index tissue sample,
j index an m/miRNA pair, and consider that expression levels are
measured on the logarithmic scale. Further, let mRNAi
j represent the
level of the putative target mRNA in the ith tissue sample of the jth
pair; Ago2i and Ago134i be levels of Ago 2 and Ago 1, 3 and 4
(combined); miRNAi
j and miRNAi
2j be levels of the targeting miRNA
in the jth pair and the combined levels from other miRNAs; and ei
j
be a random error term assumed to be normally distributed. As
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composed of Ago 2 and Ago 1, 3 or 4 are obtained as products of
miRNAi
j and Ago2i or Ago134i respectively, and analogously for such
RISCs composed of miRNAs not under explicit study.
mRNA
j
i~b
j
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j
1Ago2imiRNA
j
izb
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Under model (2), if the jth m/miRNA pair have a targeting
relationship then b1
j,0 (indicating a negative relationship between
expression levels of the mRNA and putatively targeting Ago 2
RISC proxy) would be anticipated. Therefore, a targeting
relationship between the jth m/miRNA pair under consideration
can be inferred by evaluating the no-targeting relationship
hypothesis H0: b1
j=0 vs. HA: b1
j,0. To contrast this approach
with marginal expression level comparisons of mRNAs to
miRNAs, note that an alternative to correlating m- and miRNA
levels and evaluating the analogous no-targeting hypothesis H0:
r
j=0 vs. HA: r
j,0 (where r represents the true correlation level
between m- and miRNA expression levels) would be to estimate
the simple linear regression:
mRNA
j
i~b
j
0zb
j
1miRNA
j
ize
j
i ð3Þ
and evaluate the hypothesis H0: b1
j=0 vs. HA: b1
j,0. Of the other
effect terms in (2), b5
j has arguably the most compelling physical
interpretation - if the m/miRNA possess a targeting relationship
(as evidenced by rejection of the no-targeting hypothesis), b5
j is
anticipated to be positive and scaling in magnitude with b1
j due to
the aforementioned competition for targeting sites between RISCs
composed of Ago 2 and Ago 1, 3 or 4. The remainder of covariates
and effects used in (2) are included to conform to statistical
modeling standards that require inclusion of individual covariates
in models that analyze interaction terms (e.g. miRNAi
j and Ago2i
terms), and to have a full representation of the variety of possible
effects justified by the system biology (e.g. Ago2imiRNAi
2j).
Expression data
Regression models (2) and (3) were developed on and fit to data
from two studies in which both human m- and miRNA expression
levels were measured on a reasonably large set of tissue samples. A
study of nasopharyngeal cancer (NPC) by researchers in Madison,
WI and elsewhere [10,42] derived whole genome Affymetrix
hgu133plus2 microarrays for mRNA profiling, a custom cDNA
array for miRNA profiling and RT-PCR for the expression of
Epstein-Barr (EBV) genes. Data are available on 31 NPC and 10
normal tissue samples. The second data source was derived from
that produced from a study of miRNA expression patterns over a
wide variety of tumor and normal tissue types conducted by the
Broad Institute [43]. This data collection measures m- and
miRNA expression across 67 tissue samples from 10 different
normal and tumor tissue types, each tissue type is represented by at
least 5 sample observations. Additionally, we merged the Madison
and Broad data to create a third dataset in order to fit (2) and (3) to
data from the largest number of tissue samples possible. The
merged dataset measured m- and miRNA expression across 108
tissue samples from 12 different normal and tissue types (the tissue
states from the Madison dataset were not represented in the Broad
study). Details of the Madison, Broad and combined data
collections is provided in Protocol S1.
Known target pairs
In order to validate the system biological regression model, the
TarBase miRNA target database [44] was used to derive a set of
m/miRNA target pairs that both had been previously validated
through the use of gene mRNA and protein-specific techniques
(such as PCR, luciferase reporters and immunoblotting) and were
represented in the Madison and Broad datasets. (We did not
include relationships that were supported by microarray data
alone.) In total, there were 76 such m/miRNA target pairs that
were commonly measured in both the Madison and Broad
datasets and that fit the above criteria (these target pairs were used
in the combined data analysis), and 23 additional pairs measured
in the Madison data alone. See Table S1 for information
pertaining to each of these m/miRNA target pairs.
We note that TarBase classifies target pairs into those reported
to result in cleavage or translational repression. To assure that the
known target pairs used in this study are competent for observable
cleavage, we examined the original studies supporting their
inclusion in TarBase. We found no reason to reject any of the
pairs labeled in TarBase as resulting in mRNA cleavage as being
so competent. However, simultaneous translational repression and
cleavage of was demonstrated by a number of target pairs
classified in TarBase as translationally repressive [25], and in other
studies the use of only protein to miRNA comparisons could not
justify such a distinction. Based on our examination of the
supporting studies and underlying system biology (as previously
described), we did not reject any of the known target pairs based
on their TarBase cleavage/translational repression classification
and instead regarded all target pairs as competent for Ago 2
RISC-mediated cleavage.
Computationally predicted target pairs
To evaluate the performance of the system biological regression
model on computationally predicted but unverified m/miRNA
target pairs we used the results of sequence-based comparisons
summarized in the miRBase [45–47] and TargetScan databases
and expression data from the Madison dataset to derive a set of
putative target pairs that met three criteria: 1) They were predicted
by both miRBase and TargetScan simultaneously, rather than
either database singularly; 2) The putative targeting miRNAs in
the pairs under consideration were previously identified as
differentially expressed between NPC and normal tissue samples
[10]; 3) The putative targeted mRNAs in the pairs were those that
had above median expression variability. These criteria were used
to assure confidence in both the computational target predictions
as well as the data used to verify them. The use of putative target
pairs simultaneously predicted by both miRBase and TargetScan
was motivated by the relatively low overlap between predicted
target pairs from these databases – conditional on the miRNA
under consideration, TargetScan averaged 301 predicted targets
meeting criteria (2) and (3) and miRBase averaged 379, with 48 in
common. Constraining the analysis to those pairs with differen-
tially expressed miRNAs and targeted mRNAs with above average
expression variability assured that there was sufficient variability in
expression levels to permit a statistical analysis to be conducted.
(Using mRNAs with above median mean expression rather than
variability yielded no substantial differences in the results of our
study.) In total, there were 874 putative m/miRNA target pairs
that were evaluated using the Madison dataset. See Table S2 for
the specific predicted target pairs studied.
Model refinement
The Madison, Broad and combined data collections each
exhibit a number of idiosyncratic data effects that might affect the
Statistical Use of RISC in miRNA Identification
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Madison and Broad datasets consist of expression measurements
from multiple tissue types with highly differentiated expression
profiles not directly related to m/miRNA targeting. In the
Madison data the tumor samples exhibit varying levels of EBV
activity, which has been related to the up- and downregulation of a
wide variety of genes both previously [48] and in the Madison data
set [42]. In the Broad data, no measurements for Ago 3 expression
are available. Finally, in addition to the idiosyncratic effects from
the Madison and Broad datasets individually, the composition of
the merged dataset from two data studies can be anticipated to
introduce complications to even a marginal analysis of m/miRNA
expressions.
To compensate for these issues, when analyzing target pair
expressions isolated from the Madison data we added two
covariates to model (2): a dichotomous variable representing
tumor/normal tissue sample state and the expression of the EBV
gene EBNA 1. When analyzing target pairs from the Broad data,
we added a vector of dichotomous covariates representing tissue
type to compensate for tissue type effects and substituted terms
aggregating only Ago 1 and 4 for those using Ago 1, 3 and 4. In
marginal analyses of the Madison and Broad datasets, no
compensation for tissue state was made – as described below,
introduction of similar dichotomous variables to model (3) had no
effect on the substantive results of the marginal analyses. When
analyzing target pairs from the combined dataset, we added to
model (3) a dichotomous covariate that represented the dataset
origin (Madison/Broad) of the observation under analysis, and
added to model (2) the expression of the EBV gene EBNA 1, a
vector of dichotomous covariates representing tissue state, and a
dichotomous covariate that represented dataset origin.
Model selection and hypothesis testing
As for (2) and (3), models that include idiosyncratic data
covariates can be used to infer a targeting relationship for the jth
m/miRNA pair by evaluating the suggested no targeting
relationship hypothesis. Evaluation of such a hypothesis is typically
performed via a t-test, and for marginal m/miRNA comparisons
using any of the Madison, Broad or combined datasets this
procedure is appropriate as the number of parameters are
relatively low compared to the number of tissue samples available.
However, the high parameterization of the system biological
models motivated an alternative analysis based on AIC score
minimization [49]. From a fully specified model containing both
system biology and idiosyncratic data effects, minimum AIC
submodels were computed and examined to determine whether
the proxy variable to RISCs composed of Ago 2 and the putatively
targeting miRNA was retained as a covariate, and if so, whether
the effect of that variable was negative. For observational studies,
estimated parameters in models selected for parsimony are
sufficient to infer an effect of the associated covariate and so such
cases were taken as rejections of the no targeting hypothesis.
Additionally, we note that models selected by the AIC criterion
can be regarded as implicitly passing a cross-validation test [50].
Therefore, there is a strong relationship between our technique
and those that would be predicated upon dividing the data into
training and validation sets (e.g. for developing a predictive model
for mRNA expression, in which putatively targeting miRNAs
might be evaluated as a potential predictor).
Randomization controls
To evaluate the significance of the numbers of positive
identifications we repeatedly applied the marginal and system
biology-based regression model approaches to randomized control
data, recording the number of m/miRNA pairs identified as
targeting for each repetition. Two complementary randomization
schemes were used. In the ‘‘no-targeting null’’ scheme miRNA
expressions from each pair under study were permuted across tissue
samples, holdingthem/miRNA pairing constant – i.e. we condition
on the set of m/miRNA expression levels in a given pair, but we
randomize their association by resampling the observed miRNA
levels. (This randomization was done separately in the two sources
to preserve dataset-specific effects in the combined dataset analysis.)
By contrast, in our ‘‘random pairs’’ scheme sets of non-targeting m/
miRNA pairs were constructed by independently sampling
unrelated m- and miRNAs from those under study (i.e. from the
set of known target pairs), thus randomizing the pairings while
holding the expression levels unchanged across tissue samples.
For the analysis of the known target pair data, multiple (1000)
iterations of both randomization procedures were used to
construct no-targeting null and random pairs distributions of
numbers of positive identification. These distributions provided
the basis for calculating p-values for the numbers of positively
identified target pairs actually obtained by the marginal m/
miRNA comparisons and system biology-based regression models.
Under the no-targeting null randomization, dependency between
m- and miRNA expressions is explicitly removed. Therefore the
distributions of numbers of identifications across repetitions
obtained from this procedure can be regarded to be what might
be expected if none of the m/miRNA pairs under consideration
had true targeting relationships, and the p-values correspond to
tests of the hypothesis that the statistical procedure detects more
targeting relationships that what would be anticipated if none of
the m/miRNA pairs under consideration were bona fide target
pairs. Further, the median numbers of identifications from the
distributions can be used to infer measures of test specificity. We
note that the random pairs procedure does not guarantee that the
pairs under analysis do not have a targeting relationship (although
known target pairs are rejected from those used in the method, it is
possible that the m/miRNA pair is targeting but not yet verified as
such), and so inflated numbers of identifications relative to what
might be observed under the no-targeting null are expected. In
other respects, the distribution and p-values of observed numbers
of identifications against the random pairs distribution can be used
in the same manner as those from the no-targeting null.
We performed two different analyses that verified the intuitions
and results from our randomization tests on the known target pair
data. To assure that our no-targeting null distributions were
composed of a sufficient number of samples, we reconstructed no-
targeting null distributions for the Madison data using 10000
iterations of the procedure described above (rather than the 1000
originally used), and recomputed p-values for the numbers of
positive identifications obtained by the marginal and model-based
procedures. These p-values were substantially identical to those
obtained using 1000 iterations, and considering the heavy
computational resources these procedures require we therefore
constrained our analysis to the 1000 iteration case. Next, to verify
our expectations regarding inflated numbers of identifications in
the random pairs distribution we constructed a version of this
distribution for the Madison data that was composed of randomly
paired m/miRNA expressions taken from the full set of
measurements (rather than the subset of m- and miRNAs involved
in known target pairs), recomputed p-values as previously and
compared these p-values to those originally obtained. In this
analysis, no effort was made to remove known target pairs from
those randomly sampled. The results of this version of the random
pairs scheme are described below, however the test strongly
verified our original intuitions.
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conditioned on miRNA and used no-targeting null distributions to
obtain 95% upper bounds for the numbers of verifications that
might observed from either the marginal comparisons or system
biology-based models if none of the predicted m/miRNA target
pairs were bona fide. The numbers obtained from the marginal and
system biology-based methods on the actual data were then
compared to these bounds to provide an indicator of the relative
commonality of the results and an informal assessment of the
specificity of the methods, analogous to those obtained on the
known target pairs. The 95% upper bounds of the no-targeting
null distributions were generated using 100 iterations – again,
considering the computational resources required we regarded this
number as sufficient to obtain a reasonable estimate of the 95%
level.
Implementation
We began by analyzing the expression data from known target
pairs. Marginal m/miRNA comparisons were made initially in
order to provide a performance baseline for the regression models
that incorporated system biological covariates. For the Madison
and Broad data analyses, we calculated Pearson correlation
statistics on m/miRNA expression levels to measure negative
marginal associations, and R
2 statistics from the simple linear
regression described in model (3) to determine the amount of
variation in targeted mRNA expressions attributable to that of
targeting miRNA. For the combined data analysis partial
correlations of m/miRNA expression controlling for data source
were calculated, and adjusted R
2 statistics were computed to
compensate for the increase in model complexity due to the
introduction of the dichotomous data origin covariate. (A partial
correlation is a measure of the amount of common variation
between two variables after accounting for the effects of a set of
related covariates on both. It is analogous to a standard marginal
correlation between two variables, which does not account for
covariate effects. An adjusted R
2 statistic is a measure of model fit
analogous to the standard R
2 statistic that compensates for the
number of covariates in the model. See [51], Chapter 7.10 and 7.7
for technical descriptions of the partial correlation and adjusted R
2
statistic respectively.) In each data analysis using marginal
methods, the total numbers of positive identifications of m/
miRNA target pairing obtained from evaluation of the no-
targeting hypothesis through a t-test at the 5% level were obtained.
Next, the performance of the system biological regression model
on the data from known target pairs was evaluated. Partial
correlation statistics for pairs of targeted mRNAs and proxies to
RISCs constructed of targeting miRNA and Ago 2, adjusted R
2
statistics, and numbers of positive identifications of m/miRNA
target pairing obtained from use of the minimum AIC submodel
procedures on the versions of model (2) that included data
idiosyncratic covariates were computed and compared to the
analogous baselines from the marginal m/miRNA comparisons.
The number of positive identifications were additionally evaluated
using the randomization controls to assure that we obtained
greater numbers of identifications than what would be expected
under the null hypothesis of none of the m/miRNA pairs under
analysis being a legitimate target pair.
We continued by analyzing the computationally predicted
target pairs using the Madison dataset. For each putative target
pair, the simple linear regression described in model (3) and the
version of the system biology-based regression model (2) that
incorporated idiosyncratic data effects was used to evaluate the no-
targeting hypothesis through a t-test at the 5% level and the
minimum AIC submodel procedure respectively. The results from
the marginal procedure provided a baseline for evaluating the
performance of the system biology-based regression model. The
total numbers of verifications both the marginal and system
biology-based procedures were conditioned on miRNA and
compared directly to one another.
Our analyses were implemented as scripts in the R program-
ming language [52], which were executed on Macintosh OS X
computers with installations of R 2.8.0 (earlier versions of R were
used at earlier stages in our analysis). Dataset S1 contains the
scripts and associated data used to study the known target pairs in
the Madison, Broad and combined datasets. Alternatively, the first
author may be contacted to provide the archive directly. The
archive is commented and can be used to provide further
information regarding our procedures, or to rerun our analyses
on any system with an R installation (available through the
Comprehensive R Archive Network, http://cran.r-project.org).
Please direct any questions regarding the archive to the first
author.
Results
Marginal m/miRNA associations identify very few known
target pairs
Because the known target pairs under examination were
previously observed to have targeting relationships, it was
anticipated that the marginal correlations between m/miRNA
expression levels using any of the Madison, Broad and combined
datasets would typically be significantly negative. Contrary to these
expectations, the sensitivity of marginal m/miRNA expression
level comparisons was demonstrated to be quite low. Only 5 of the
99 target pairs in the Madison dataset, 6 of the 76 pairs in the
Broad dataset and 7 of the 76 pairs in the combined dataset have
significantly negative marginal relationships between m/miRNA
expressions (Table 1), and the majority of observed correlations
are positive (Figure 2). An example of the relationship between
marginal m- and miRNA expression levels in the Madison data is
provided in Figure 3 (top row, left column). The example provided
compares miR-17-5p to E2F1, a known oncogene. Although miR-
17-5p is known to target E2F1, the relationship between m- and
miRNA levels is positive.
As suggested in Methods, adding idiosyncratic data effects to
our marginal m/miRNA comparison in (3) resulted in nearly no
differences in the number of known m/miRNA target pairs
successfully identified as such. Using t-testing procedures to
evaluate the no-targeting hypothesis after doing so yields 3 of
Table 1. Identification performances of marginal and
regression models.
Marginal
comparison
AIC-optimal
submodel
Madison 5/99 (5.05%) 33/99 (33.33%)
Broad 6/76 (7.89%) 20/76 (26.31%)
Madison (Common subset) 2/76 (2.63%) 27/76 (35.52%)
Combined 7/76 (9.21%) 36/76 (47.36%)
The AIC-optimal submodel procedures associated with regression models
compensating for biological and idiosyncratic covariates capture more of the
known targeting relationships than marginal m/miRNA expression level
comparisons in all of the datasets under consideration. The Madison (Common
subset) data refers to those target pairs in the Madison dataset which were in
common with those in the Broad dataset.
doi:10.1371/journal.pcbi.1000516.t001
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such in the Madison, Broad and combined datasets respectively.
Similarly, a variety of data transformations were used to attempt to
generate an improvement in the overall results without success,
and the model fits were checked to assure that the results were not
due to systemic outlier effects, model misspecifications or non-
normal error terms.
Finally, it was notable that the number of detections obtained by
marginal comparisons was well within what might be observed
under either the no-targeting null or random pairs distributions
(Figure 5, second row). For the analysis of the Madison data, the p-
values of the number of positive identifications under the no-
targeting null and random pairs distributions were 0.491 and
0.279 respectively, for the Broad data p=0.193 and 0.800
respectively, and for the combined analysis p=0.947 and 0.419
(Table 2). In the context of the previously discussed identification
performance, these values suggest that the specificity of the
marginal procedure approximates the false positive rate under the
null hypothesis of no targeting, and therefore that marginal m/
miRNA expression level comparisons are as likely to detect
evidence of a targeting relationship for unrelated m- and miRNAs
as they are for bona fide target pairs.
miRNA abundance alone explains only a small fraction of
targeted mRNA variation
The observed R
2 values from marginal m/miRNA expression
level comparisons using data from known target pairs range from
less than 0.001 to 0.365 with an average score of 0.061 for the
pairs in the Madison data, less than 0.001 to 0.196 with an average
of 0.035 for the pairs in the Broad data, and 0.008 to 0.880 with
an average score of 0.411 for the pairs in the combined data
(Figure 2). In the case of the Madison and Broad analyses, these
values indicate that variation in the expression levels of targeting
miRNAs explains only a small proportion of that in targeted
mRNA levels. As a consequence of this, it would be anticipated
that marginal comparisons of m/miRNA expression levels would
not be useful for determining whether or not a targeting
relationship exists, and therefore the low R
2 values rationalize
the previously observed performance of the marginal m/miRNA
comparisons in identifying the known target pairs as such. In the
case of the combined data analysis the observed R
2 scores are
substantially larger. However, the true relationships of the known
m- and miRNA target pairs were not captured when analyzing the
combined dataset with the marginal model. Therefore, these high
R
2 scores simply suggest that the majority of the observed variance
in targeted mRNA expression is explained by the origin of the data
observation, rather than the appropriateness of the model.
Statistical models including system biological covariates
better represent the known target pair data
The mean and range of adjusted R
2 values for fits of the system
biological regression model were (0.524, 20.102–0.922) for the
Madison data, (0.310, 20.077–0.602) for the Broad data and
(0.712, 0.055–0.974) for the combined data (Figure 4). The
increases in observed R
2 scores from the baselines obtained from
fits of the marginal model indicate that the regression model
Figure 2. Marginal expression level comparisons of known target pairs. Marginal correlations of m- and miRNA expression levels are
typically and inappropriately positive in all datasets under analysis. Further, in the Madison and Broad datasets the amount of variation in targeted
mRNA expression captured by that of targeting miRNA is extremely low. In the combined dataset, high R
2 values are indicative only of the amount of
variation in mRNA expression due to data origin.
doi:10.1371/journal.pcbi.1000516.g002
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levels, even after compensating for its increased complexity.
Because inclusion of the system biological covariates yielded a
model that explained greater amounts of variation in target
mRNA levels explained than the marginal model, it was
anticipated that it would also better represent the true negative
relationship between m/miRNA expression levels from the known
target pairs. In fact, partial correlations between targeted mRNAs
and proxies to targeting Ago 2 RISCs under model (2) were
appropriately negative at substantially higher rates than marginal
m/miRNA correlations (53% vs. 38%, 59% vs. 42% and 61% vs.
32% for the target pairs in the Madison, Broad and combined
datasets respectively). Additionally, there was a reduction in
observed correlation scores taken across the sample of m/miRNA
target pairs (mean marginal and partial scores were (0.0934,
20.0247), (0.057, 20.012) and (0.232, 20.083) for the Madison,
Broad and combined data). To formalize this comparison, a null
hypothesis of equality of marginal and partial correlation scores
Figure 3. Marginal and system biology-compensated E2F1 and miR-17-5p expression levels. E2F1 and miR-17-5p expression levels in the
Madison data are compared marginally in the top left and after compensation for biological and idiosyncratic covariates on the top right. Analogous
results for the OSU data are provided in the bottom row. In either dataset, marginal RNA expression levels are not representative of the known
targeting relationship between miR-17-5p and E2F1. After compensation the relationship between these RNAs can be observed.
doi:10.1371/journal.pcbi.1000516.g003
Table 2. Significances of numbers of correct identifications under randomization nulls.
No-targeting null, marginal
comparison
Random pairs, marginal
comparison
No-targeting null, AIC-optimal
submodel
Random pairs, AIC-optimal
submodel
Madison 0.491 0.279 0.008 0.053
Broad 0.193 0.800 0.096 0.241
Combined 0.947 0.419 0.001 0.072
Table 2 provides p-values of the numbers of correct identifications for each of the Madison, Broad and combined datasets under no-targeting null and random pairs
distributions. The number of correct identifications obtained after compensating for biological and idiosyncratic covariates is typically at least marginally significant in
any of the datasets under study, using either randomization null. Marginal comparisons do not yield significant numbers of correct identifications in any of the cases
under study.
doi:10.1371/journal.pcbi.1000516.t002
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Wilcoxon rank-sum test (p=0.014, 0.018 and ,0.001 for the
Madison, Broad and combined data).
Validation of these results consisted of checking the model fits
for evidence of systemic outlier effects, model misspecifications or
non-normal error terms, as was done for the marginal model fits.
A comparative example of the model fits achieved in the Madison
data is provided in the top row, right column of Figure 3. After
controlling for system biological and idiosyncratic covariates, the
relationship between miR-17-5p (which was positive under the
marginal model) is appropriately negative.
In a further examination, the effects of the covariates used in the
AIC-optimal submodels of the fits of (2) on the Madison data were
studied to assure that the model was not overspecified. Of the
variety of covariates used in the version of (2) compensating for the
idiosyncratic data effects, only the dichotomous variable indicating
tissue type found low levels of use in the AIC-optimal submodel –
in fact, it was never included in the AIC-optimal submodels,
indicating that tissue type never had a substantive effect on a
targeted mRNA level after compensating for other effects. Because
few if any of the known m/miRNA target pairs under
consideration have been previously observed to be differentially
expressed in NPC, this might be reasonable. Alternatively, this
result can be explained by noting that EBV expression in the
Madison data is highly associated with NPC, and therefore
statistical control of EBV expressions rather than tissue type may
be sufficient for both.
Related to this analysis, the estimated effects of proxies for
targeting RISCs composed of Ago 1, 3 and 4 from the AIC-
optimal submodels were compared to those composed of Ago 2 in
order to assure that the model was performing in a reasonable
manner. Figure 6 displays the relationships of estimated effects of
targeting Ago 2 RISC proxies to targeting Ago 1, 3 and 4 RISC
proxies, for AIC-optimal submodels estimated on the Madison
data in which both covariates were included and the estimated
effect of the targeting Ago 2 RISC covariate was appropriately
negative (there were 13 such cases out of the 33 in which the effect
of the targeting covariate was so). It can be observed that, as
anticipated, the estimated effects of targeting Ago 1, 3 and 4
RISCs on targeted mRNA levels are indeed generally positive with
effect sizes scaling with those of targeting Ago 2 RISCs.
Overall, these results demonstrate that the relationships
between targeted mRNAs and proxies to targeting Ago 2 RISC,
compensating for other relevant biological covariates, better
represent the actual relationship of the known target pairs than
marginal m/miRNA expression level correlations.
Figure 4. System biology-compensated expression level comparisons of known target pairs. Improvements in the percentages of
variation in targeted mRNA expression are observed through use of the adjusted R
2 statistic. Partial correlations of proxies to targeting Ago 2 RISCs
and targeted mRNAs are lower than those of m/miRNA expressions. Paired Wilcoxon tests of the hypothesis H0: m02m1=0 vs. HA: m02m1?0 were
rejected for the Madison (p=0.0135), Broad (p=0.0186) and combined (p,0.0001) datasets, where m0 and m1 refer to mean correlations of marginal
m/miRNA expression and mean partial correlations respectively.
doi:10.1371/journal.pcbi.1000516.g004
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biology identify a substantial portion of the known
targets
Based on the improvements in model fit, it was further
anticipated that evaluating the no-targeting hypothesis using the
system biological model and the minimum AIC submodel
procedure would indicate a greater number of positive identifica-
tions of targeting relationships than obtained by marginal m/
miRNA comparisons. In fact, model (2) identified 33 of 99, 20 of
76 and 36 of 76 known m/miRNA target pairs as having
expression profiles consistent with targeting relationships in the
Madison, Broad and combined datasets respectively. This
represents up to a sevenfold increase from the baseline obtained
by marginal m/miRNA expression level comparisons (Table 1),
and demonstrates the improved sensitivity of model (2) in detecting
m/miRNA target pair relationships. We note that although under
50% of known target pairs were recovered by model (2), this level
of identification performance is similar to the individual
performances obtained by a number of sequence-based compu-
tational methods [30]. In particular, using the Madison and
combined datasets we were able to successfully identify 33 and
47% of the known targets pairs we evaluated, whereas TargetScan
and miRBase are reported to have 21 and 48% consistency with
experimentally supported target pairs.
The numbers of detections obtained by model (2) relative to
what might be expected under either of the randomization
techniques show similar improvements from the baseline obtained
by marginal m/miRNA expression level comparisons (Figure 5,
first row). For the analysis of the Madison, Broad and combined
datasets, the p-values of the number of positive identifications
under the no-targeting null were 0.008, 0.096 and 0.001
respectively. Likewise, under the random pairs distributions the
p-values were 0.053, 0.241 and 0.072. In the case of the Madison,
Broad and combined data analyses, the numbers of identifications
obtained are at least marginally significantly greater than what is
typically observed under the no-targeting null. Under the random
pairs distribution the Madison and combined data analysis show
similar results, while the number of identifications made using the
Broad data is not significantly greater than what might be
expected under the null. As suggested above we anticipated an
overall inflation in p-values under the random pairs technique due
to inadvertent sampling of as-of-yet unverified target pairs from
the sets of known target pairs used as a basis for the technique. As
discussed in Methods, to verify this intuition we performed a
secondary analysis of the number of detections obtained for the
Madison data against a random pairs distribution constructed
from the full set of m- and miRNAs for which expression
measurements were available. The p-value from this study was
Figure 5. p-values of observed correct identifications under no-targeting and random pair nulls. The AIC-optimal procedure
compensating for biological and idiosyncratic covariates yields numbers of correct identifications that are typically at least marginally significant in
any of the datasets under study, using either randomization null. In no case is the number of correct identifications achieved by marginal correlation
significantly greater than what would be expected.
doi:10.1371/journal.pcbi.1000516.g005
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the random pairs distributions as a statistical artifact and focused
our attention on the results from the no-targeting null.
In total, the results from our analysis imply that the
improvements in sensitivity for detecting target pairs obtained
through model (2) are greater than any loss in specificity that might
be incurred relative to that of the marginal procedure. The overall
specificity of (2) for rejecting non-targeting pairs in the Madison
and combined datasets are approximately 80%, as can be
observed from median numbers of acceptances under the non-
targeting null distribution. The analysis of the Broad data did not
yield significantly larger numbers of correct identifications under
either the no-targeting null or random pairs distributions, however
it is useful to note that the high number of tissue types and missing
Ago 3 measurements in the Broad dataset can be anticipated to
negatively affect our ability to detect m/miRNA target pair
relationships from expression levels. As well, the Madison dataset
was processed to provide measurements in terms of concentration
estimates that can more naturally be aggregated than the RMA
measurements provided in the Broad data.
Regression-based m/miRNA association verifies
substantial portions of the predicted target pairs as bona
fide
The overall results of evaluating the computationally predicted
m/miRNA target pairs on the Madison data with the system
biological regression model and marginal m/miRNA comparison
are described in Figure 7. (Table S2 provides further detail on
results obtained for particular m/miRNA pairs analyzed by the
system biologic regression model.) For each miRNA under
consideration, the first, second and third columns of Fig. 7 provide
the numbers of putative target pairs evaluated and positive
validations obtained by the system biological model and marginal
m/miRNA comparisons respectively. In the second and third
columns, 95% upper bounds on number of positive validations
expected under the no-targeting null are provided.
Visual inspection of Figure 7 suggests that model (2) yields
substantially more verifications than the marginal method in
nearly every case. In fact, the marginal method most often yields
no verifications of computationally predicted targets of any of the
miRNAs considered. The average percentage of predicted targets
validated by the system biologic regression model is 25.68%, taken
across all miRNAs. For 6 of the 18 miRNAs conditioned upon, the
Figure 6. Estimated effects of targeting Ago 2 and Ago 1,3,4
RISC proxies. X- and y-axes correspond to estimated effects of
targeting RISC proxies composed of Ago 2 (b1) and Ago 1, 3 or 4 (b5)o n
targeted mRNA levels for those cases where the model successfully
identifies the known targeting pair and estimates both effects in the
minimum AIC submodel. Observed values are inversely related in sign
with similar magnitudes of effect strength. This is consistent with the
hypothesized interference of observable target cleavage by RISCs
composed of Ago 2 by those composed of Ago 1,3 or 4.
doi:10.1371/journal.pcbi.1000516.g006
Figure 7. Validation of computationally predicted targets. Hash marks denote the 95% confidence level of identification numbers under the
no-targeting null for the miRNA and validation technique under consideration. Overall, 7.83% of computational predicted targets were verified using
marginal expression level comparisons, and 4 miRNAs showed substantially larger numbers of verifications than what would be typically expected.
After compensating for biological and idiosyncratic effects, 25.68% of these targets were verified, and 9 miRNAs showed large numbers of
identifications.
doi:10.1371/journal.pcbi.1000516.g007
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than what might be expected under the no-targeting null (miR-
130b, -15a, -16, -181a, -181c, -30d), and analyses conducted on
targets predicted for an additional three miRNAs (miR-192, -224
and -212) yielded numbers of identifications that were substantially
greater (p=0.08, 0.13 and 0.28 respectively). In comparison,
marginal comparisons validate an average of 7.83% of predicted
targets, and yielded three miRNAs (miR-212, -29a and –29c)
associated with significantly greater numbers of verifications than
what might be expected under the no-targeting null with one
additional miRNA (miR-133a) having a substantially greater
number (p=0.21). Although some inflation in the number of
verifications that might be observed under the no-targeting null
was incurred through when using the system biologic regression
model rather than marginal m/miRNA comparisons, the results
obtained here are roughly consistent with the performance of the
marginal and system biologic regression methods on the set of
known target pairs.
Based on these results, a further comparative inspection was
made of the distributions of the estimated marginal and Ago 2
mediated effects from fits of the miRNAs under analysis against all
mRNAs in the Madison dataset. Sample distributions for
estimated and normalized marginal effects of miR-29c and
estimated miR-30d Ago 2 RISC effects are provided in Figure 8.
(These were selected due to their high numbers of predicted target
pair verifications, as seen in Figure 7.) The estimated marginal
effects of miR-29c are clearly negatively biased, explaining the
high numbers of validations. The estimated miR-30d Ago 2 RISC
effects do not have such a bias. Instead, they demonstrate a
bimodality with a main mass centered at 0 effect and a smaller
mass centered at 21.5. Such a distribution is consistent with a
categorization of genes into two classes: those regulated by miR-
30d, and those not. Although analyses of such large-scale screen
results are ongoing, the results in Figures 7 and 8 provide further
evidence that that use of statistical models which compensate for
the system biology related to miRNA-based gene silencing are
more appropriate for validating and predicting m/miRNA
targeting relationships than marginal expression level compari-
sons.
Discussion
The effects of miRNAs on mRNA stability and translation are
presently understood to have effects on organism development and
physiological function, and have been linked to diseases such as
cancer. It is of acknowledged importance to develop greater
insight into the targeting relationships between m- and miRNAs.
In this paper, we considered the role that biology-based statistical
modeling and methods might play in the m/miRNA target
prediction problem. Currently, the statistical techniques used for
these purposes are typically based on marginal comparisons of
individual m- and miRNA expressions across tissue samples. In
Figure 8. Estimated effects of marginal miR-29c expressions and miR-30d Ago 2 RISC proxies. Distributions of miR-30d Ago 2 RISC proxy
effects across all genes measured in the Madison dataset suggest two classes of genes – those with no relationship to miR-30d, and those negatively
regulated by miR-30d. Analogous distributions of marginal miR-29c expression effects suggest no such dichotomy, and are negatively biased.
doi:10.1371/journal.pcbi.1000516.g008
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early studies verifying predicted targeting relationships were based
on transfection experiments with small numbers of samples, for
which marginal m/miRNA comparisons might be the only
procedure available. However, it has been observed previously
(and was demonstrated here) that in practice these methods
typically yield relatively disappointing results.
We hypothesized that improvements in the performance of
statistical methods for detecting m/miRNA target pair relation-
ships might be achieved through development of a statistical
model and associated hypothesis testing procedure better tied to
the underlying system biology. In an investigation of this biology in
homo sapiens we identified a number of factors that we expected to
affect the ability of marginal m/miRNA expression level
comparisons to detect targeting relationships, many related to
the dependence of the gene silencing mechanism on the
construction and varied actions of RISCs. Based on this as well
as additional information pertaining to the data under analysis, we
developed regression methodology for testing hypotheses of no
targeting relationship between m- and miRNA. Our rationale for
choosing regression methods (as opposed to other possible
statistical or computational methods) was motivated by the
balance it offered between the competing goals of fidelity to the
system biology, having a methodology with understood theoretical
underpinnings and computational tractability for analyzing large
number of putative m/miRNA target pairs, while being
appropriate to the data quality and sample size.
In comparison to procedures based on marginal m/miRNA
expressions, our models and procedures were shown to provide
substantial improvements in overall model fit and detection
performance for sets of known m/miRNA target pairs, although
the degree of such improvement was somewhat dependent on the
study design. As would be hoped, we further demonstrated that
such improvements were carried over into the problem of
validating predicted m/miRNA target pairs. Our study suggests
that use of the regression models and associated hypothesis testing
procedures developed here (or equivalent techniques based on the
system biology) represent a reasonable alternative to methods
based on marginal m/miRNA comparisons for analyzing
expression data in m/miRNA targeting studies, and in conjunc-
tion with high throughput data can be used to either verify
computationally predicted relationships or generate de novo
information regarding m/miRNA target pairs. In fact, our model
demonstrates consistency with known target pairs on par with
many computational target prediction algorithms [30].
Because there have been few systematic studies of statistical
methods for detecting m/miRNA targeting, there is little context
that can be used to help evaluate our results. The most relevant
external work is that recently conducted by Huang et al [53–55],
however there are a number of differences between our studies.
Huang et al focus on Bayesian methods to update a set of prior
probabilities of targeting relationships between m- and miRNAs
using marginal expression comparisons. These prior probabilities
are, in their reported work, highly tied to the results of
computational target prediction algorithms (in particular, Tar-
getScan). The posterior probabilities obtained through their
technique are compared to a threshold based on those obtained
from a high-confidence set of m/miRNA target pair expression
values; m/miRNA pairs with posterior targeting probabilities
meeting the threshold are accepted as valid target pairs. In
contrast, our study is framed in terms of evaluating a single m/
miRNA pair for evidence of a targeting relationship, compensating
for the underlying system biology (which includes the effects of
other targeted and targeting m- and miRNAs on the m/miRNA
pair under consideration). Our use of a hypothesis testing
framework allows us to avoid the need to set a thresholding value
based on a separate set of m/miRNA expression data for
evaluating whether potential m/miRNA pairs evidence a targeting
relationship. We do not tie our work to any particular
computational target prediction algorithm, a position we view as
appropriate given the issues with their specificity, sensitivity and
inter-algorithm consistency.
Further, the emphasis of our presentation of algorithm
development and results is substantially different from Huang et
al. We choose to focus development of a statistical method on
known m/miRNA pairs and then use the resulting procedure to
validate a set of computational target predictions. Huang et al are
primarily concerned with using their algorithm to validate
computational predictions, with verification of their method on
known target pairs taking place only on those that are represented
in their set of computational target predictions [53]. It is unclear
whether these differences in presentation have a substantial
difference in performance. The methods proposed here and by
Huang et al verify approximately the same proportion of
computational target predictions evaluated, and Huang et al [53]
demonstrate that of 19 known target pairs contained in the set of
computationally predicted targets that they attempt to evaluate, 9
are identified as such. Overall, comparing the two methods and
constructing new statistical procedures that incorporate elements
of each may be one direction for achieving further improvements
in the ability to detect m/miRNA target relationships from high-
throughput expression data.
A similar issue that this study only indirectly addresses is the
topic of how to best combine results across multiple sequence-
based computational or expression-based methods, in order to
obtain an aggregate estimate of the full set of m/miRNA target
pairs occurring in humans. Such techniques can be classified into
two categories: Those that would use sequence-based and
expression-based methods sequentially (e.g. using expression-based
methods to validate sequence-based predictions or using sequence-
based methods to rationalize de novo expression-based predictions
with a target site), and those that would use them simultaneously
(i.e. without using one type of method conditional on the results of
the other). Here, after establishing the utility of our data on known
target pairs, we demonstrate how it might be used in a sequential
study conditional on the results of sequence-based methods. To
perform either a sequential study in which sequence-based
methods are used conditional on de novo expression-based
predictions or a simultaneous study using both sequence-based
and expression-based predictions, the development of statistical
methods which can distinguish between a bona fide m/miRNA
target pair and m/miRNA pairs related through an intermediate,
targeted, translationally activating mRNA must be developed. We
are currently working on the development of such a technique.
Additional complications that ought to be addressed in such
studies is how best to handle the multiple comparisons problems
that occur due to the large number of m/miRNA pairs that might
be evaluated (which are orders of magnitude larger than those
encountered in typical differential expression studies, for example),
and how to best align results from multiple algorithms and
datasets. We feel that, much as this study utilized known m/
miRNA target pairs to validate our regression model, it is
reasonable for future proposed methods for handling these
technical problems to use them as a basis for evaluation and
validation.
Aside from our current work towards the development of a
statistical technique capable of de novo m/miRNA target pair
prediction, we are extending our work in large-scale screening of
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Our work consists of both investigating and improving our
statistical procedures for inferring such relationships as well as
aligning predictions from sequence- and expression-based meth-
ods, and by further supplementing the data used in this study with
new samples as they become available. In a study of a recent
dataset originally analyzed by Ambs et al [56], many of the results
obtained here are reiterated. Figure 3 provides an example.
Consistent with our result using the Madison data, miR-17-5p
shows no substantial relationship with E2F1 in a marginal analysis
(bottom left panel), but after controlling for the biological and
idiosyncratic covariates the true negative relationship between
them can be observed (bottom right). Based on this study, those of
Huang et al, and the continued release of high-throughput data
studies comparing m- and miRNA expression, we look forward to
the further development of statistical methods for detecting m- and
miRNA targeting relationships from expression data.
Supporting Information
Protocol S1 Protocol
Found at: doi:10.1371/journal.pcbi.1000516.s001 (0.05 MB
DOC)
Table S1 Known m/miRNA target pairs. Table S1 contains the
set of all previously observed target pairs used in this study.
Alternative nomenclature for miRNAs/genes is provided. Target-
ed genes are labeled (C) or (TR) depending on whether the target
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Table S2 Predicted m/miRNA target pairs. Table S2 contains
the set of all predicted target pairs analyzed in this study. For each
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along with a list of the genes analyzed. Predictions verified by use
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